搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Saccharomyces cerevisiae Asparagine-rich zinc finger protein AZF1 (AZF1), partial CSB-YP340419SVG
CSB-EP340419SVG
CSB-BP340419SVG
CSB-MP340419SVG
CSB-EP340419SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Autographa californica nuclear polyhedrosis virus Occlusion-derived virus envelope protein E18 CSB-YP340420ARA
CSB-EP340420ARA
CSB-BP340420ARA
CSB-MP340420ARA
CSB-EP340420ARA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Autographa californica nuclear polyhedrosis virus Uncharacterized 12.4 kDa protein in IE1-IEN intergenic region CSB-YP340421ARA
CSB-EP340421ARA
CSB-BP340421ARA
CSB-MP340421ARA
CSB-EP340421ARA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Autographa californica nuclear polyhedrosis virus Immediate-early protein IE-0 (IE-0) CSB-YP340422ARA
CSB-EP340422ARA
CSB-BP340422ARA
CSB-MP340422ARA
CSB-EP340422ARA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Choristoneura fumiferana nuclear polyhedrosis virus Viral cathepsin (Vcath) CSB-YP340423CJU
CSB-EP340423CJU
CSB-BP340423CJU
CSB-MP340423CJU
CSB-EP340423CJU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lymantria dispar multicapsid nuclear polyhedrosis virus Serine/threonine-protein kinase 1 (PK1) CSB-YP340424LRP
CSB-EP340424LRP
CSB-BP340424LRP
CSB-MP340424LRP
CSB-EP340424LRP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Orgyia pseudotsugata multicapsid polyhedrosis virus 8.9 kDa basic protein (P8.9) CSB-YP340425OEU
CSB-EP340425OEU
CSB-BP340425OEU
CSB-MP340425OEU
CSB-EP340425OEU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Paraponera clavata Delta-paraponeritoxin-Pc1a CSB-YP340426PCP
CSB-EP340426PCP
CSB-MP340426PCP
CSB-EP340426PCP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Endopolygalacturonase B (pgaB) CSB-YP340428AVD
CSB-EP340428AVD
CSB-BP340428AVD
CSB-MP340428AVD
CSB-EP340428AVD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative cutinase CSB-YP340429PJK
CSB-EP340429PJK
CSB-BP340429PJK
CSB-MP340429PJK
CSB-EP340429PJK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phosphoglycerate kinase, cytosolic (C1PGK) CSB-YP340430TJA
CSB-EP340430TJA
CSB-BP340430TJA
CSB-MP340430TJA
CSB-EP340430TJA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lipase CSB-YP340432FFT
CSB-EP340432FFT
CSB-BP340432FFT
CSB-MP340432FFT
CSB-EP340432FFT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Homarus americanus Guanine nucleotide-binding protein G (i) subunit alpha CSB-YP340433HWO
CSB-EP340433HWO
CSB-BP340433HWO
CSB-MP340433HWO
CSB-EP340433HWO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Protein prgH (prgH), partial CSB-YP340434SXB1
CSB-EP340434SXB1
CSB-BP340434SXB1
CSB-MP340434SXB1
CSB-EP340434SXB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium Ethanolamine utilization protein EutM (eutM) CSB-YP340435SXB
CSB-EP340435SXB
CSB-BP340435SXB
CSB-MP340435SXB
CSB-EP340435SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Highly acidic elicitin 26 (B26) CSB-YP340436PJL
CSB-EP340436PJL
CSB-BP340436PJL
CSB-MP340436PJL
CSB-EP340436PJL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Sporulation-specific mitogen-activated protein kinase SMK1 (SMK1) CSB-YP340437SVG
CSB-EP340437SVG
CSB-BP340437SVG
CSB-MP340437SVG
CSB-EP340437SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Valine amino-acid permease (BAP3), partial CSB-YP340438SVG
CSB-EP340438SVG
CSB-BP340438SVG
CSB-MP340438SVG
CSB-EP340438SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Brefeldin A resistance protein (bfr1), partial CSB-YP340439SXV
CSB-EP340439SXV
CSB-BP340439SXV
CSB-MP340439SXV
CSB-EP340439SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles albimanus Heat shock protein 70 A2 (HSP70A2), partial CSB-YP340440AKR
CSB-EP340440AKR
CSB-BP340440AKR
CSB-MP340440AKR
CSB-EP340440AKR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>